Zymeworks BC Inc (NASDAQ:ZYME) shares, rose in value on Friday, March 28, with the stock price down by -1.12% to the previous day’s close as strong demand from buyers drove the stock to $12.37.
Actively observing the price movement in the last trading, the stock closed the session at $12.51, falling within a range of $12.205 and $12.6356. The value of beta (5-year monthly) was 1.132. Referring to stock’s 52-week performance, its high was $17.70, and the low was $7.97. On the whole, ZYME has fluctuated by -7.27% over the past month.
With the market capitalization of Zymeworks BC Inc currently standing at about $867.72 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-04.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 94.41M, with a low estimate of 8.6M and a high estimate of 40M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 20.65M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ZYME’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of ZYME currently trading nearly -0.69% and -8.88% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.33, while the 7-day volatility ratio is showing 4.20% which for the 30-day chart, stands at 5.34%. Furthermore, Zymeworks BC Inc (ZYME)’s beta value is 1.16, and its average true range (ATR) is 0.66.
A comparison of Zymeworks BC Inc (ZYME) with its peers suggests the former has fared considerably weaker in the market. ZYME showed an intraday change of -1.12% in last session, and over the past year, it grew by 18.15%%.
Data on historical trading for Zymeworks BC Inc (NASDAQ:ZYME) indicates that the trading volumes over the past 10 days have averaged 0.59 and over the past 3 months, they’ve averaged 528.36K. According to company’s latest data on outstanding shares, there are 68.96 million shares outstanding.
Nearly 4.07% of Zymeworks BC Inc’s shares belong to company insiders and institutional investors own 97.32% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.42 million shares as on 2025-03-14, resulting in a short ratio of 8.16. According to the data, the short interest in Zymeworks BC Inc (ZYME) stood at 1010.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 3.84 million. The stock has fallen by -15.51% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ZYME stock heading into the next quarter.
